173 related articles for article (PubMed ID: 16278672)
1. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
Worrillow LJ; Allan JM
Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
[TBL] [Abstract][Full Text] [Related]
2. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
4. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
5. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
[TBL] [Abstract][Full Text] [Related]
6. The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells.
Cooley N; Elder RH; Povey AC
Toxicology; 2010 Jan; 268(1-2):111-7. PubMed ID: 20025921
[TBL] [Abstract][Full Text] [Related]
7. DNA repair and chromosomal alterations.
Natarajan AT; Palitti F
Mutat Res; 2008 Nov; 657(1):3-7. PubMed ID: 18801460
[TBL] [Abstract][Full Text] [Related]
8. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.
Moynahan ME; Cui TY; Jasin M
Cancer Res; 2001 Jun; 61(12):4842-50. PubMed ID: 11406561
[TBL] [Abstract][Full Text] [Related]
9. Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1.
Vernole P; Muzi A; Volpi A; Terrinoni A; Dorio AS; Tentori L; Shah GM; Graziani G
Mutat Res; 2011 Jul; 712(1-2):40-8. PubMed ID: 21570414
[TBL] [Abstract][Full Text] [Related]
10. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
Claij N; Te Riele H
Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
[TBL] [Abstract][Full Text] [Related]
11. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
[TBL] [Abstract][Full Text] [Related]
12. [DNA homologous recombination repair in mammalian cells].
Popławski T; Błasiak J
Postepy Biochem; 2006; 52(2):180-93. PubMed ID: 17078508
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
14. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
15. Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair.
Roos WP; Christmann M; Fraser ST; Kaina B
Cell Death Differ; 2007 Aug; 14(8):1422-32. PubMed ID: 17464330
[TBL] [Abstract][Full Text] [Related]
16. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
[TBL] [Abstract][Full Text] [Related]
17. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
18. Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect.
Campbell MR; Wang Y; Andrew SE; Liu Y
Oncogene; 2006 Apr; 25(17):2531-6. PubMed ID: 16331258
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
[TBL] [Abstract][Full Text] [Related]
20. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.
Barwell J; Pangon L; Hodgson S; Georgiou A; Kesterton I; Slade T; Taylor M; Payne SJ; Brinkman H; Smythe J; Sebire NJ; Solomon E; Docherty Z; Camplejohn R; Homfray T; Morris JR
J Med Genet; 2007 Aug; 44(8):516-20. PubMed ID: 17483304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
